Cognitive rehabilitation using immersive virtual reality in stroke patients

Not Applicable

• Conditions: Cognitive function improvement in post-stroke patients; Nervous System Diseases

• Registration Number: ISRCTN14922230
• Lead Sponsor: Vytautas Magnus University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-01-03
• Last Update Posted: 15 January 2024
• Study Completion: 2024-10-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 156

Inclusion Criteria

1. Confirmed diagnosis of stroke
2. No severe cognitive impairment (fully understand the purpose and terms of the study)
3. The native language is Lithuanian
4. At least 3 days after the arrival at the rehabilitation center
5. Being able to sit

Exclusion Criteria

1. To be over the age of 85 years
2. To have epilepsy
3. To have such a degree of aphasia that a patient cannot understand spoken instructions and cannot answer meaningfully
4. To have the psychiatric diagnoses established
5. To experience unilateral neglect
6. To be characterized by severe motor disorders that restrict movements of both hands
7. To have other communication impairments that may prevent the patient from understanding task instructions or the purpose of the study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Short-term visual memory is assessed using The Medical College of Georgia Complex Figures (MCGCF), forms A and B, during pre-assessment and post-assessment.<br> 2. General cognitive functions and five domains (attention, memory, verbal fluency, language and visuospatial abilities) Addenbrooke's Cognitive Examination III forms A and B during pre-assessment and post-assessment.<br> 3. Visual search, working memory, and executive functions are measured using the Trail Making tests Part A and Part B during pre-assessment and post-assessment.<br> 4. Memory and learning are assessed using The Mnemonic Similarity Task C and D parts during pre-assessment and post-assessment.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Depression symptoms are measured using The Patient Health Questionnaire – 9 at pre-assessment and post-assessment.<br> 2. Anxiety symptoms are measured using The Generalized Anxiety Disorder scale - 7 at pre-assessment and post-assessment.<br> 3. Psychomotor functions are measured using The Finger Tapping Test at pre-assessment and post-assessment.<br><br> The several questionnaires additionally include during the post-assessment of experimental and active control groups:<br> 4. The sense of presence in a virtual environment is measured using The Igroup Presence Questionnaire (IPQ) at post-assessment.<br> 5. The system's usability is measured using The System Usability Scale (SUS) at post-assessment.<br>